Ensysce Biosciences (ENSCW) Retained Earnings (2017 - 2025)
Ensysce Biosciences (ENSCW) reported Retained Earnings of -$139.7 million for Q4 2025, down 7.85% year-over-year from -$151.6 million in Q4 2024, and down 2.02% quarter-over-quarter from -$137.0 million in Q3 2025.
Ensysce Biosciences (ENSCW) Retained Earnings (2017 - 2025) Analysis & Trends
Ensysce Biosciences (ENSCW) has 9 years of Retained Earnings data on file, last reported at -$139.7 million in Q4 2025.
- Retained Earnings for Q4 2025 came in at -$139.7 million, down 7.85% year-over-year; the trailing twelve-month figure through Dec 2025 was -$139.7 million (down 7.85% YoY), and the FY2025 annual result was -$139.7 million, down 7.85% from the prior year.
- Retained Earnings declined to -$139.7 million in Q4 2025 per ENSCW's latest filing, from -$137.0 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$2.9 million in Q1 2021 and troughed at -$139.7 million in Q4 2025.
- A 5-year average of -$106.9 million and a median of -$116.7 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2021 and 2025: Retained Earnings plunged 5052.51% in 2021, then fell 5.2% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$85.8 million in 2021, then fell by 29.22% to -$110.9 million in 2022, then decreased by 9.58% to -$121.6 million in 2023, then retreated by 6.57% to -$129.5 million in 2024, then slipped by 7.85% to -$139.7 million in 2025.
- Business Quant data shows ENSCW's Retained Earnings at -$139.7 million in Q4 2025, -$137.0 million in Q3 2025, and -$133.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Ensysce Biosciences | - | - | - | -139.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -139.72 Mn |
| Sep 30, 2025 | -136.95 Mn |
| Jun 30, 2025 | -133.22 Mn |
| Mar 31, 2025 | -131.49 Mn |
| Dec 31, 2024 | -129.54 Mn |
| Sep 30, 2024 | -125.98 Mn |
| Jun 30, 2024 | -126.64 Mn |
| Mar 31, 2024 | -124.67 Mn |
| Dec 31, 2023 | -121.56 Mn |
| Sep 30, 2023 | -118.05 Mn |
| Jun 30, 2023 | -115.40 Mn |
| Mar 31, 2023 | -113.13 Mn |
| Dec 31, 2022 | -110.93 Mn |
| Sep 30, 2022 | -105.41 Mn |
| Jun 30, 2022 | -95.51 Mn |
| Mar 31, 2022 | -87.50 Mn |
| Dec 31, 2021 | -85.85 Mn |
| Sep 30, 2021 | -75.00 Mn |
| Jun 30, 2021 | -57.84 Mn |
| Mar 31, 2021 | -2.92 Mn |